Cancer drugmaker Bristol Myers to build its largest R&D facility outside US in India by 2025
The $100-million facility, inaugurated by Boerner on Monday, is expected to employ over 1,500 employees and will be used to enhance its drug development through the use of digital technologies and artificial intelligence, he said in his keynote speech at the BioAsia conference.
Andhra Pradesh Christopher Boerner Bristol Myers Biocon Group Syngene International Bristol Myers Squibb Biocon Group
Source: indiatimes.com